240 related articles for article (PubMed ID: 34826608)
1. Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease.
Mesa-Infante V; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Barroso-Chinea P
Mol Cell Neurosci; 2022 Jan; 118():103684. PubMed ID: 34826608
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons.
Pong K; Xu RY; Baron WF; Louis JC; Beck KD
J Neurochem; 1998 Nov; 71(5):1912-9. PubMed ID: 9798915
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of glial cell-derived neurotrophic factor loaded collagen scaffolds in ex vivo organotypic brain slice Parkinson's disease models.
Ucar B; Humpel C
Brain Res Bull; 2019 Jul; 149():86-95. PubMed ID: 31004735
[TBL] [Abstract][Full Text] [Related]
4. Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.
Drinkut A; Tillack K; Meka DP; Schulz JB; Kügler S; Kramer ER
Cell Death Dis; 2016 Sep; 7(9):e2359. PubMed ID: 27607574
[TBL] [Abstract][Full Text] [Related]
5. Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro.
Eggert K; Schlegel J; Oertel W; Würz C; Krieg JC; Vedder H
Neurosci Lett; 1999 Jul; 269(3):178-82. PubMed ID: 10454161
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons.
Pong K; Xu RY; Beck KD; Zhang TJ; Louis JC
J Neurochem; 1997 Sep; 69(3):986-94. PubMed ID: 9282920
[TBL] [Abstract][Full Text] [Related]
7. Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
Mahato AK; Kopra J; Renko JM; Visnapuu T; Korhonen I; Pulkkinen N; Bespalov MM; Domanskyi A; Ronken E; Piepponen TP; Voutilainen MH; Tuominen RK; Karelson M; Sidorova YA; Saarma M
Mov Disord; 2020 Feb; 35(2):245-255. PubMed ID: 31840869
[TBL] [Abstract][Full Text] [Related]
8. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
Barroso-Chinea P; Cruz-Muros I; Aymerich MS; Rodríguez-Díaz M; Afonso-Oramas D; Lanciego JL; González-Hernández T
Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.
Yue P; Gao L; Wang X; Ding X; Teng J
Neurochem Res; 2017 May; 42(5):1366-1374. PubMed ID: 28247332
[TBL] [Abstract][Full Text] [Related]
11. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
12. Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase.
Perrinjaquet M; Vilar M; Ibáñez CF
J Biol Chem; 2010 Oct; 285(41):31867-75. PubMed ID: 20682772
[TBL] [Abstract][Full Text] [Related]
13. GM1 ganglioside enhances Ret signaling in striatum.
Newburn EN; Duchemin AM; Neff NH; Hadjiconstantinou M
J Neurochem; 2014 Aug; 130(4):541-54. PubMed ID: 24821093
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats.
Renko JM; Mahato AK; Visnapuu T; Valkonen K; Karelson M; Voutilainen MH; Saarma M; Tuominen RK; Sidorova YA
J Parkinsons Dis; 2021; 11(3):1023-1046. PubMed ID: 34024778
[TBL] [Abstract][Full Text] [Related]
15. LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson's Disease Cell Model.
Zheng W; Han X; Han B; Li G; Gan J; Wang T; Xu B; He J; Du W; Cao X; Wang Z
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446291
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
17. H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.
Fonseca CP; Gama S; Saavedra A; Baltazar G
Biochim Biophys Acta; 2014 Jul; 1842(7):927-34. PubMed ID: 24632468
[TBL] [Abstract][Full Text] [Related]
18. GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease.
Kramer ER; Liss B
FEBS Lett; 2015 Dec; 589(24 Pt A):3760-72. PubMed ID: 26555190
[TBL] [Abstract][Full Text] [Related]
19. The Actin Cytoskeleton Is Involved in Glial Cell Line-Derived Neurotrophic Factor (GDNF)-Induced Ret Translocation into Lipid Rafts in Dopaminergic Neuronal Cells.
Li L; Song H; Mu P; Xu M; Liu C; Wang Y; Qin Y; Sun S; Gao J; Wang T; Gao D
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880247
[TBL] [Abstract][Full Text] [Related]
20. Induction of glial cell line-derived neurotrophic factor by the squamosamide derivative FLZ in astroglia has neuroprotective effects on dopaminergic neurons.
Bao XQ; Wang L; Yang HY; Hou LY; Wang QS; Zhang D
Brain Res Bull; 2020 Jan; 154():32-42. PubMed ID: 31669104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
